Also known as: Cannabis writing in British India, 1920s · Indian Hemp Drugs literature, interwar period

Cannabis Literature in South Asia During the 1920s

Administrative reports, Geneva negotiations, and Ayurvedic revival shaped 1920s South Asian cannabis writing.

Sourced and fact-checked
4 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

The 1920s were bureaucratically rich but scientifically thin. Excise reports documented sales and cultivation; Ayurvedic compendia reprinted old texts; and Indian diplomats at Geneva defended traditional use—but nobody did controlled clinical work. The modern claim that 'India single-handedly saved cannabis' is folklore; India actually accepted most international controls in exchange for cultural exemptions.

Context: What the 1920s Inherited

By 1920, the definitive English-language reference on South Asian cannabis was already a generation old: the seven-volume Report of the Indian Hemp Drugs Commission (1894–95), which had surveyed bhang, ganja, and charas use across British India and concluded that moderate use produced no significant harm [1]. Writers in the 1920s cited it constantly rather than replacing it.

Indigenous knowledge traditions—Ayurveda, Unani, and Siddha—had documented cannabis (as vijaya, bhanga, or qinnab) for centuries, and 1920s compilations largely reproduced older Sanskrit and Persian material rather than generating new pharmacology Strong evidence[2]. The decade's distinctive contribution was not scientific but bureaucratic. Provincial excise departments produced annual administration reports quantifying licensed ganja and bhang sales, and the Government of India was drawn into international drug control negotiations that required it to defend its domestic cannabis regime in writing.

Colonial Excise and Administrative Literature

The bulk of 1920s cannabis writing in South Asia consisted of provincial excise reports. Bengal, Bombay, Madras, the United Provinces, Punjab, Assam, and Burma each published annual administration volumes tallying ganja cultivation in licensed tracts, licensed vends, tax revenue, and prosecutions [2]. These are the closest thing to primary quantitative data for the period.

A representative type of document is the Note on the Cultivation of Ganja and its Preparation for the Market in Bengal, a departmental memorandum that circulated within the Indian Civil Service. These texts describe the Naogaon ganja mahal system, in which cultivation was restricted to a defined tract and supervised by a Ganja Cultivation Officer—a system formalised in the 1870s and maintained through the 1920s Strong evidence[2].

These administrative sources are reliable for bureaucratic facts (acreage, tax rates, licensing procedures) and unreliable for anything about physiological or psychological effects, which they rarely addressed. They are essential for understanding colonial cannabis policy infrastructure but not for assessing drug efficacy or harms.

The Geneva Conferences and Indian Diplomatic Submissions

The most internationally consequential 1920s cannabis text involving South Asia was Egypt's proposal at the Second Opium Conference in Geneva (1924–25) to add cannabis to the international narcotics control regime. The Indian delegation, led by J. Campbell (representing the Government of India), argued against strict international control, defending traditional bhang use on cultural and religious grounds and warning that prohibition would push users toward alcohol or more harmful drugs [3][4].

The compromise language in the resulting 1925 International Opium Convention permitted domestic use of Indian hemp for cultural and medical purposes while restricting international trade in resin (charas) [3]. The Indian written submissions to Geneva—reproduced in League of Nations records—are among the most substantive policy documents on South Asian cannabis produced in the decade Strong evidence.

On the 'saved cannabis' myth: A persistent modern folklore claims that 'India single-handedly saved cannabis at Geneva.' The historical record is more complex. India argued for cultural exemptions and traditional-use carve-outs, not against international control in principle. India accepted export restrictions on charas and participated in the control regime that followed. The language about 'saving' reflects later nationalist reframing rather than what the 1920s documents actually show Disputed.

Indigenous and Ayurvedic Writing

The 1920s coincided with a broader revival of Ayurvedic and Unani publishing in India, tied to nationalist cultural politics. Compendia such as Kaviraj Nagendra Nath Sen Gupta's Ayurvedic System of Medicine (1919, reprinted through the 1920s) included entries on vijaya (cannabis) and reproduced classical indications from texts like the Sharngadhara Samhita and Bhavaprakasha Weak / limited.

These works are valuable as records of what practitioners believed and prescribed, but they are compilations, not clinical studies. The common modern claim that 'ancient Indian medicine proved cannabis treats [condition]' based on 1920s Ayurvedic reprints conflates textual tradition with empirical evidence Anecdote. The classical Sanskrit and Persian texts themselves rarely frame their indications as empirically proven; that language is a later import. A 1920s Ayurvedic compendium citing a 300-year-old text does not constitute a 1920s clinical trial.

Popular and Reformist Writing

A smaller but politically consequential strand of 1920s writing came from Indian temperance and social reform movements, which increasingly grouped bhang and ganja with alcohol as targets of moral concern. Vernacular pamphlets in Bengali, Hindi, and Marathi warned against ganja smoking, often citing anecdotes about sadhus, beggars, or the institutionally confined rather than any systematic evidence Anecdote.

This reformist literature is historically important because it shaped the political ground on which post-independence Indian cannabis policy was eventually built, culminating in the 1985 Narcotic Drugs and Psychotropic Substances Act. But as a source on what cannabis actually does to users, it is polemical and anecdotal rather than descriptive or empirical.

What the 1920s Did Not Produce

Notably absent from 1920s South Asian cannabis literature: controlled clinical studies, chemical analysis (cannabinoid identification did not begin until the 1940s with Adams and continued through Mechoulam in the 1960s), systematic botanical fieldwork on landrace variation, and any original ethnography of user populations beyond what the 1894 Indian Hemp Drugs Commission had already documented Strong evidence[1].

Anyone citing a '1920s Indian medical study' proving efficacy for a modern condition is almost certainly either misattributing later work, repeating a chain of secondary references that dead-ends at the 1894 commission or an undated Ayurvedic compendium, or conflating diplomatic writing with clinical evidence. The honest reading of the decade is that it was administratively sophisticated and scientifically thin.

Sources

How this page was made

Generation history

Oct 31, 2026
Revision
Jul 25, 2026
Fact-check pass — raised 9 flags
Jul 26, 2026
Fact-check pass — raised 2 flags
Jul 26, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.